{
    "clinical_study": {
        "@rank": "161485", 
        "arm_group": [
            {
                "arm_group_label": "Intravenous patient-controlled analgesia", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravenous morphine solution 0.2 mg / ml in PCA mode without basal infusion, 1mg bolus demand and lockout of 8 minutes."
            }, 
            {
                "arm_group_label": "Continuous lumbar plexus (LP) block analgesia", 
                "arm_group_type": "Experimental", 
                "description": "Continuous lumbar plexus (LP) block analgesia. Continuous infusion of a solution of 0.1% bupivacaine in PCA mode, programmed at 8 ml / h.\nRescue bolus 5 ml and 30 minutes lockout"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is evaluate the efficacy of perioperative continuous lumbar plexus\n      block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery\n      for hip fractures, expressed as a reduction of ischemic events per subject."
        }, 
        "brief_title": "Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture", 
        "condition": [
            "Hip Fractures", 
            "Perioperative Myocardial Ischemia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Myocardial Ischemia", 
                "Coronary Artery Disease", 
                "Fractures, Bone", 
                "Hip Fractures", 
                "Ischemia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with hip fracture within 48 hours of evolution\n\n          -  Known coronary artery disease:\n\n        Previous myocardial infarction Chronic stable angina Atypical angina with positive\n        exercise test for coronary flow failure. Evidence of coronary artery disease with\n        ultrasound, scintigraphic or         angiographic compatible\n\n          -  Patients with at least two of the risk factors for coronary heart disease as defined\n             by Wallace (1998)\n\n        Exclusion Criteria:\n\n          -  Patients receiving orthopedic treatment.\n\n          -  Patients with coagulopathy, clinic or laboratory.\n\n          -  Patients with sepsis or infection of the catheter insertion site of lumbar plexus.\n\n          -  Patients with neurological diseases evolving.\n\n          -  Patients disoriented, or dementia.\n\n          -  CKD stage IV National Kidney Foundation (2)\n\n          -  Glomerular filtration rate between 15 and 29 mL/min/1, 73 m2\n\n          -  Patients unable to use the Numeric Rating Scale (NRS) to assess pain.\n\n          -  Patients with non-sinus rhythm or conduction abnormalities (right bundle   branch\n             block or left, atrioventricular block) in the admission ECG\n\n          -  Patients with pacemaker.\n\n          -  Enrolled patients with acute coronary syndrome or decompensated cardiovascular\n             disease at entry.\n\n          -  Allergy to any of the drugs of the protocol.\n\n          -  Inability to understand or unaided sign informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "31", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01961895", 
            "org_study_id": "Altermatt 09-148"
        }, 
        "intervention": [
            {
                "arm_group_label": "Continuous lumbar plexus (LP) block analgesia", 
                "intervention_name": "Continuous lumbar plexus (LP) block analgesia", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Intravenous patient-controlled analgesia", 
                "intervention_name": "Intravenous patient-controlled analgesia", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Continuous lumbar plexus (LP) block analgesia", 
        "lastchanged_date": "October 11, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile", 
                        "state": "Region Metropolitana", 
                        "zip": "8330024"
                    }, 
                    "name": "Division de Anestesia - Pontificia Universidad Catolica de Chile"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile", 
                        "state": "Regi\u00f3n Metropolitana", 
                        "zip": "8330024"
                    }, 
                    "name": "Divisi\u00f3n de Anestesia - Facultad de Medicina Pontificia Universidad Cat\u00f3lica"
                }
            }
        ], 
        "location_countries": {
            "country": "Chile"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Effect of Perioperative Continuous Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture.", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Chile: Institutional Review Board", 
                "Chile: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "evaluate the efficacy of perioperative continuous lumbar plexus block in reducing the risk of cardiac ischemic events of elderly patients undergoing surgery for hip fractures, expressed as a reduction of ischemic events per subject.", 
            "safety_issue": "Yes", 
            "time_frame": "3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01961895"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Major cardiovascular events (myocardial infarction, acute pulmonary edema, arrhythmias).", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }, 
            {
                "measure": "hospital death", 
                "safety_issue": "Yes", 
                "time_frame": "3 days"
            }, 
            {
                "measure": "Death at 30, 90 and 360 days after surgery", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Perioperative Pain Intensity, measured in numerical rating scale (NRS).", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }, 
            {
                "measure": "Evaluate Adverse events (hypotension, respiratory depression, systemic toxicity, etc..)", 
                "safety_issue": "No", 
                "time_frame": "3 days"
            }
        ], 
        "source": "Pontificia Universidad Catolica de Chile", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pontificia Universidad Catolica de Chile", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}